524632
SHUKRAPHAR
Start SIP
Invest Now
Start SIP in SHUKRAPHAR
Performance
- Low
- ₹42
- High
- ₹42
- 52 Week Low
- ₹12
- 52 Week High
- ₹65
- Open Price₹42
- Previous Close₹40
- Volume51,819
- 50 DMA₹45.45
- 100 DMA₹41.76
- 200 DMA₹34.37
Investment Returns
- Over 1 Month -17.49%
- Over 3 Month + 5.68%
- Over 6 Month + 117.8%
- Over 1 Year + 89.42%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 63.7
- PEG Ratio
- 0.2
- Market Cap Cr
- 1,859
- P/B Ratio
- 28.2
- Average True Range
- 2.91
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -2.58
- RSI
- 45.09
- MFI
- 61.1
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
Current Price
₹42.45
+
2.02
(5%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹43.86
- 50 Day
- ₹45.45
- 100 Day
- ₹41.76
- 200 Day
- ₹34.37
Resistance and Support
42.45
- R3 42.45
- R2 42.45
- R1 42.45
- S1 42.45
- S2 42.45
- S3 42.45
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-04 | Quarterly Results | (Revised) alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-11-13 | Quarterly Results | |
| 2025-10-03 | Others | Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-08-13 | Quarterly Results | |
| 2025-06-04 | Final Dividend |
Shukra Pharmaceuticals F&O
About Shukra Pharmaceuticals
- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- Managing Director
- Mr. Dakshesh Rameshchandra Shah
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹42 As on 08 February, 2026 | 01:21
The Market Cap of Shukra Pharmaceuticals is ₹1858.8 Cr As on 08 February, 2026 | 01:21
The P/E ratio of Shukra Pharmaceuticals is 63.7 As on 08 February, 2026 | 01:21
The PB ratio of Shukra Pharmaceuticals is 28.2 As on 08 February, 2026 | 01:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.